Top

BMC Ophthalmology

Published in:

Open Access 01-12-2016 | Case report

Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease: a case report

Authors: Seong Joon Ahn, Sun Jin Hwang, Byung Ro Lee

Published in: BMC Ophthalmology | Issue 1/2016

Abstract

Background

Adult-onset Still’s disease is a systemic inflammatory disease which presents with uveitis and scleritis in the eye. Intravitreal dexamethasone implants are used for the treatment of refractory uveitis.

Case presentation

A 19-year-old woman diagnosed to have adult-onset Still’s disease for fevers, joint pain, and a salmon-colored bumpy rash presented with scleritis and uveitis in the left eye. Topical and systemic steroids with oral methotrexate failed to control the inflammation. We performed intravitreal injections of dexamethasone implants for side effects of steroid and refractory ocular inflammation. The therapy resulted in improvements in the patient’s uveitis with reductions in scleral vessel engorgement and redness. There was no recurrence of uveitis or scleritis during 4 months following treatment.

Conclusions

Intravitreal injections of dexamethasone implants may result in clinical improvements of refractory scleritis combined with uveitis.

Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol. 2005;50:351–63.CrossRefPubMed

Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–76.CrossRefPubMed

Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–96.CrossRefPubMed

Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis therapy. Ophthalmology. 2012;119:51–8.CrossRefPubMed

Boyer DS, Yoon YH, Belfort Jr R, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121:1904–14.CrossRefPubMed

Haller JA, Bandello F, Belfort Jr R, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118:2453–60.CrossRefPubMed

Burkholder BM, Moradi A, Thorne JE, Dunn JP. The Dexamethasone Intravitreal Implant for Noninfectious Uveitis: Practice Patterns Among Uveitis Specialists. Ocul Immunol Inflamm. 2015;23:444–52.CrossRefPubMed

Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16.CrossRefPubMed

Cush JJ, Medsger Jr TA, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum. 1987;30:186–94.CrossRefPubMed

10.

Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19:424–30.PubMed

11.

Priori R, Colafrancesco S, Gattamelata A, Di Franco M, Di Tondo U, Valesini G. Adult-onset Still disease: a rare disorder with a potentially fatal outcome. Auto Immun Highlights. 2010;1:53–9.CrossRefPubMedPubMedCentral

12.

Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD. Adult onset Still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis. 1992;51:529–32.CrossRefPubMedPubMedCentral

13.

Lowder C, Belfort Jr R, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129:545–53.CrossRefPubMed

14.

Nascimento H, Franca M, Garcia LG, Muccioli C, Belfort Jr R. Subconjunctival dexamethasone implant for non-necrotizing scleritis. J Ophthalmic Inflamm Infect. 2013;3:7.CrossRefPubMedPubMedCentral

15.

Sainz de la Maza M, Jabbur NS, Foster CS. An analysis of therapeutic decision for scleritis. Ophthalmology. 1993;100:1372–6.CrossRefPubMed

16.

Fraunfelder FT, Watson PG. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976;60:227–30.CrossRefPubMedPubMedCentral

Title: Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease: a case report
Authors: Seong Joon Ahn
Sun Jin Hwang
Byung Ro Lee
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI: https://doi.org/10.1186/s12886-016-0380-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease: a case report

Abstract

Background

Case presentation

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Comparison of human corneal cell density by age and corneal location: an in vivo confocal microscopy study

Choroidal thickness in Chinese patients with non-arteritic anterior ischemic optic neuropathy

Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results

The association between intraocular pressure and different combination of metabolic syndrome components

Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia

Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series